Matthew L. Posard's Net Worth
$27.2 Million
Who is Matthew L. Posard?
Matthew L. Posard has an estimated net worth of $27.2 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, Nautilus Biotechnology, Inc., DermTech, Inc., HALOZYME THERAPEUTICS, INC., Trovagene, Inc., and Talis Biomedical Corp.
SEC CIK
Matthew L. Posard's CIK is 0001543792
Past Insider Trading and Trends
2013 was Matthew L. Posard's most active year for acquiring shares with 12 total transactions. Matthew L. Posard's most active month to acquire stocks was the month of April. 2013 was Matthew L. Posard's most active year for disposing of shares, totalling 19 transactions. Matthew L. Posard's most active month to dispose stocks was the month of March. 2021 saw Matthew L. Posard paying a total of $2,225,496.00 for 160,786 shares, this is the most they've acquired in one year. In 2013 Matthew L. Posard cashed out on 105,450 shares for a total of $3,170,096.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ILLUMINA INC (ILMN) Snapshot price: $125
Sr VP & General Manager
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$53.92 | -$95,743.36 | 30.86K |
Scheduled
|
May 30
| ||
Form 4
|
—
|
0
|
$44.20 | -$1,326,461.38 | 30.86K |
Scheduled
|
Apr 11
| ||
Form 4
| -5.00% | -1.62K |
$53.77 | -$87,322.48 | 30.86K |
Mar 8
| |||
Form 4
| +15.01% | 4.16K |
$50.63 | -$15,189.00 | 31.87K |
Jan 29 - Jan 31
| |||
Form 4
| -4.78% | -1.39K |
$51.62 | -$71,751.80 | 27.71K |
Jan 27 - Jan 28
| |||
Form 4
| +73.14% | 12.29K |
—
|
—
| 29.1K |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nautilus Biotechnology, Inc. (NAUT) Snapshot price: $2.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 50K |
$4.51 | $225,505.00 | 50K |
Nov 30 - Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DermTech, Inc. (DMTK) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.15% | 35.71K |
—
|
—
| 158.22K |
Jun 1
| |||
Form 4
| +27.58% | 26.48K |
—
|
—
| 122.5K |
May 26
| |||
Form 4
| +10.54% | 9.16K |
—
|
—
| 96.02K |
May 26
| |||
Form 4
| +64.00% | 33.9K |
$29.50 | $999,991.00 | 86.86K |
Jan 11
| |||
Form 4
| +17.79% | 8K |
—
|
—
| 52.97K |
Jun 17
| |||
Form 4
| +27.51% | 9.7K |
$6.94 | $67,331.88 | 44.97K |
Apr 29
| |||
Form 4
| +20.50% | 6K |
—
|
—
| 35.26K |
Jan 30
| |||
Form 4
| +120.54% | 15.99K |
—
|
—
| 29.26K |
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.95% | -29.88K |
$56.53 | -$1,689,293.70 | 69.87K |
Aug 12 - Aug 14
| |||
Form 4
| -16.70% | -20.00K |
$50.32 | -$1,006,300.00 | 99.75K |
Jun 11 - Jun 12
| |||
Form 4
| +5.74% | 6.5K |
—
|
—
| 119.75K |
Apr 25
| |||
Form 4
| +7.67% | 8.06K |
—
|
—
| 113.25K |
May 5
| |||
Form 4
| -22.19% | -30.00K |
$56.89 | -$1,706,550.00 | 105.19K |
Dec 2 - Dec 6
| |||
Form 4
| +4.81% | 6.21K |
—
|
—
| 135.19K |
May 5
| |||
Form 4
| +4.23% | 5.23K |
—
|
—
| 128.98K |
May 5
| |||
Form 4
| +7.68% | 8.83K |
—
|
—
| 123.75K |
Apr 30
| |||
Form 4
| +11.85% | 12.17K |
—
|
—
| 114.92K |
May 2
| |||
Form 4
| +11.22% | 10.36K |
—
|
—
| 102.75K |
May 2
| |||
Form 4
| +18.06% | 14.13K |
—
|
—
| 92.39K |
May 4
| |||
Form 4
| +34.80% | 20.2K |
—
|
—
| 78.25K |
May 4
| |||
Form 4
| +29.36% | 13.18K |
—
|
—
| 58.05K |
May 6
| |||
Form 4
| +124.38% | 24.88K |
—
|
—
| 44.88K |
May 13
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trovagene, Inc. (CRDF) Snapshot price: $2.3
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||